Navigation Links
PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call

BOSTON, July 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release Fourth Quarter and Fiscal Year 2009 financial results on Monday, August 10, 2009 after the close of the stock market. The announcement will be available on PAREXEL's website at and on the PR Newswire website at

PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Tuesday, August 11, 2009 to discuss the results. To access the webcast, visit PAREXEL's website at, and click on the Investor Relations menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (706) 758-4950 and ask to join PAREXEL's Fourth Quarter and Fiscal Year 2009 conference call.

About the Company

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

Jill Baker, Vice President of Investor Relations (781) 434-4118

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL International to Present at the Wachovia Equity Conference
2. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
3. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
4. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
5. PAREXEL Receives BioSingapore Award for Best Performing CRO
6. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
7. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
8. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
9. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
10. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
11. PAREXEL Receives Best CRO Award from Scrip
Post Your Comments:
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):